Benzinga's Top Ratings Upgrades, Downgrades For March 15, 2022

Upgrades

For Turquoise Hill Resources Ltd TRQ, BMO Capital upgraded the previous rating of Underperform to Market Perform. Turquoise Hill Resources earned $0.78 in the fourth quarter, compared to $0.79 in the year-ago quarter. The stock has a 52-week-high of $26.73 and a 52-week-low of $9.75. At the end of the last trading period, Turquoise Hill Resources closed at $26.55.

According to BMO Capital, the prior rating for Turquoise Hill Resources Ltd TRQ was changed from Underperform to Market Perform. In the fourth quarter, Turquoise Hill Resources showed an EPS of $0.78, compared to $0.79 from the year-ago quarter. The current stock performance of Turquoise Hill Resources shows a 52-week-high of $26.73 and a 52-week-low of $9.75. Moreover, at the end of the last trading period, the closing price was at $26.55.

According to DA Davidson, the prior rating for Washington Federal Inc WAFD was changed from Neutral to Buy. Washington Federal earned $0.71 in the first quarter, compared to $0.51 in the year-ago quarter. At the moment, the stock has a 52-week-high of $38.06 and a 52-week-low of $29.01. Washington Federal closed at $34.22 at the end of the last trading period.

For Realty Income Corp O, Wolfe Research upgraded the previous rating of Peer Perform to Outperform. For the fourth quarter, Realty Income had an EPS of $0.94, compared to year-ago quarter EPS of $0.84. At the moment, the stock has a 52-week-high of $74.60 and a 52-week-low of $61.43. Realty Income closed at $64.88 at the end of the last trading period.

According to Wolfe Research, the prior rating for UDR Inc UDR was changed from Peer Perform to Outperform. In the fourth quarter, UDR showed an EPS of $0.54, compared to $0.49 from the year-ago quarter. The current stock performance of UDR shows a 52-week-high of $61.06 and a 52-week-low of $42.83. Moreover, at the end of the last trading period, the closing price was at $56.02.

Barclays upgraded the previous rating for Fortive Corp FTV from Equal-Weight to Overweight. For the fourth quarter, Fortive had an EPS of $0.79, compared to year-ago quarter EPS of $0.70. The stock has a 52-week-high of $79.87 and a 52-week-low of $56.06. At the end of the last trading period, Fortive closed at $56.96.

B of A Securities upgraded the previous rating for Ascendis Pharma A/S ASND from Neutral to Buy. For the fourth quarter, Ascendis Pharma had an EPS of $2.14, compared to year-ago quarter EPS of $3.15. At the moment, the stock has a 52-week-high of $178.71 and a 52-week-low of $96.97. Ascendis Pharma closed at $102.64 at the end of the last trading period.

Benchmark upgraded the previous rating for Zoom Video Communications Inc ZM from Hold to Buy. Zoom Video Comms earned $1.29 in the fourth quarter, compared to $1.22 in the year-ago quarter. The current stock performance of Zoom Video Comms shows a 52-week-high of $406.48 and a 52-week-low of $94.51. Moreover, at the end of the last trading period, the closing price was at $94.64.

BMO Capital upgraded the previous rating for LiveRamp Holdings Inc RAMP from Market Perform to Outperform. LiveRamp Holdings earned $0.14 in the third quarter, compared to $0.14 in the year-ago quarter. At the moment, the stock has a 52-week-high of $58.74 and a 52-week-low of $33.42. LiveRamp Holdings closed at $33.84 at the end of the last trading period.

According to Goldman Sachs, the prior rating for The Mosaic Co MOS was changed from Neutral to Buy. In the fourth quarter, Mosaic showed an EPS of $1.95, compared to $0.57 from the year-ago quarter. The current stock performance of Mosaic shows a 52-week-high of $64.71 and a 52-week-low of $28.26. Moreover, at the end of the last trading period, the closing price was at $58.10.

According to Baird, the prior rating for GoodRx Holdings Inc GDRX was changed from Neutral to Outperform. For the fourth quarter, GoodRx Holdings had an EPS of $0.09, compared to year-ago quarter EPS of $0.08. The current stock performance of GoodRx Holdings shows a 52-week-high of $48.05 and a 52-week-low of $13.44. Moreover, at the end of the last trading period, the closing price was at $13.62.

For Northern Oil & Gas Inc NOG, Johnson Rice upgraded the previous rating of Accumulate to Buy. In the fourth quarter, Northern Oil & Gas showed an EPS of $1.06, compared to $0.64 from the year-ago quarter. The current stock performance of Northern Oil & Gas shows a 52-week-high of $29.10 and a 52-week-low of $11.40. Moreover, at the end of the last trading period, the closing price was at $23.84.

Atlantic Equities upgraded the previous rating for W.W. Grainger Inc GWW from Neutral to Overweight. W.W. Grainger earned $5.44 in the fourth quarter, compared to $3.66 in the year-ago quarter. The stock has a 52-week-high of $527.06 and a 52-week-low of $386.37. At the end of the last trading period, W.W. Grainger closed at $483.40.

According to Morgan Stanley, the prior rating for Heartland Express Inc HTLD was changed from Underweight to Equal-Weight. Heartland Express earned $0.26 in the fourth quarter, compared to $0.22 in the year-ago quarter. At the moment, the stock has a 52-week-high of $20.07 and a 52-week-low of $13.85. Heartland Express closed at $14.19 at the end of the last trading period.

See all analyst ratings upgrades.

Downgrades

According to UBS, the prior rating for Zynga Inc ZNGA was changed from Buy to Neutral. Zynga earned $0.09 in the fourth quarter, compared to $0.09 in the year-ago quarter. At the moment, the stock has a 52-week-high of $11.37 and a 52-week-low of $5.57. Zynga closed at $8.86 at the end of the last trading period.

For Nektar Therapeutics NKTR, BTIG downgraded the previous rating of Buy to Neutral. Nektar Therapeutics earned $0.79 in the fourth quarter, compared to $0.65 in the year-ago quarter. The stock has a 52-week-high of $23.50 and a 52-week-low of $3.98. At the end of the last trading period, Nektar Therapeutics closed at $4.16.

For Prelude Therapeutics Inc PRLD, B of A Securities downgraded the previous rating of Buy to Neutral. In the third quarter, Prelude Therapeutics showed an EPS of $0.66, compared to $5.25 from the year-ago quarter. The stock has a 52-week-high of $62.75 and a 52-week-low of $7.62. At the end of the last trading period, Prelude Therapeutics closed at $7.75.

According to Credit Suisse, the prior rating for China Eastern Airlines Corp Ltd CEA was changed from Neutral to Underperform. The current stock performance of China Eastern Airlines shows a 52-week-high of $26.19 and a 52-week-low of $17.00. Moreover, at the end of the last trading period, the closing price was at $17.01.

According to Credit Suisse, the prior rating for China Southern Airlines Co Ltd ZNH was changed from Outperform to Neutral. NoneThe current stock performance of China Southern Airlines shows a 52-week-high of $39.96 and a 52-week-low of $25.07. Moreover, at the end of the last trading period, the closing price was at $25.81.

Goldman Sachs downgraded the previous rating for Hormel Foods Corp HRL from Neutral to Sell. Hormel Foods earned $0.44 in the first quarter, compared to $0.41 in the year-ago quarter. At the moment, the stock has a 52-week-high of $53.19 and a 52-week-low of $40.48. Hormel Foods closed at $50.04 at the end of the last trading period.

For Evolv Technologies Holdings Inc EVLV, Stifel downgraded the previous rating of Buy to Hold. The stock has a 52-week-high of $12.90 and a 52-week-low of $2.81. At the end of the last trading period, Evolv Technologies closed at $2.99.

For Coupa Software Inc COUP, Oppenheimer downgraded the previous rating of Outperform to Perform. In the fourth quarter, Coupa Software showed an EPS of $0.19, compared to $0.17 from the year-ago quarter. The current stock performance of Coupa Software shows a 52-week-high of $286.22 and a 52-week-low of $89.25. Moreover, at the end of the last trading period, the closing price was at $89.82.

Piper Sandler downgraded the previous rating for Coupa Software Inc COUP from Overweight to Neutral. Coupa Software earned $0.19 in the fourth quarter, compared to $0.17 in the year-ago quarter. The current stock performance of Coupa Software shows a 52-week-high of $286.22 and a 52-week-low of $89.25. Moreover, at the end of the last trading period, the closing price was at $89.82.

According to Mizuho, the prior rating for Nektar Therapeutics NKTR was changed from Buy to Neutral. Nektar Therapeutics earned $0.79 in the fourth quarter, compared to $0.65 in the year-ago quarter. The current stock performance of Nektar Therapeutics shows a 52-week-high of $23.50 and a 52-week-low of $3.98. Moreover, at the end of the last trading period, the closing price was at $4.16.

Cowen & Co. downgraded the previous rating for Nektar Therapeutics NKTR from Outperform to Market Perform. Nektar Therapeutics earned $0.79 in the fourth quarter, compared to $0.65 in the year-ago quarter. The stock has a 52-week-high of $23.50 and a 52-week-low of $3.98. At the end of the last trading period, Nektar Therapeutics closed at $4.16.

See all analyst ratings downgrades.

Initiations

With an Overweight rating, Barclays initiated coverage on Legend Biotech Corp LEGN. The price target seems to have been set at $53.00 for Legend Biotech. For the third quarter, Legend Biotech had an EPS of $0.43, compared to year-ago quarter EPS of $0.25. The current stock performance of Legend Biotech shows a 52-week-high of $58.00 and a 52-week-low of $24.00. Moreover, at the end of the last trading period, the closing price was at $31.02.

Dawson James initiated coverage on Arcimoto Inc FUV with a Neutral rating. In the third quarter, Arcimoto showed an EPS of $0.31, compared to $0.15 from the year-ago quarter. The current stock performance of Arcimoto shows a 52-week-high of $21.42 and a 52-week-low of $4.51. Moreover, at the end of the last trading period, the closing price was at $5.89.

Ladenburg Thalmann initiated coverage on Compass Therapeutics Inc CMPX with a Buy rating. The price target for Compass Therapeutics is set to $7.00. The current stock performance of Compass Therapeutics shows a 52-week-high of $11.00 and a 52-week-low of $1.25. Moreover, at the end of the last trading period, the closing price was at $1.44.

Evercore ISI Group initiated coverage on Zymeworks Inc ZYME with an Outperform rating. The price target for Zymeworks is set to $15.00. In the fourth quarter, Zymeworks showed an EPS of $0.95, compared to $0.74 from the year-ago quarter. The current stock performance of Zymeworks shows a 52-week-high of $39.41 and a 52-week-low of $5.94. Moreover, at the end of the last trading period, the closing price was at $6.00.

With a Buy rating, Truist Securities initiated coverage on Frontier Communications Parent Inc FYBR. The price target seems to have been set at $40.00 for Frontier Communications. The stock has a 52-week-high of $35.15 and a 52-week-low of $23.24. At the end of the last trading period, Frontier Communications closed at $25.10.

Craig-Hallum initiated coverage on Bioventus Inc BVS with a Buy rating. The price target for Bioventus is set to $30.00. For the fourth quarter, Bioventus had an EPS of $0.26, compared to year-ago quarter EPS of $2.32. The current stock performance of Bioventus shows a 52-week-high of $19.94 and a 52-week-low of $11.40. Moreover, at the end of the last trading period, the closing price was at $12.66.

With an Outperform rating, SVB Leerink initiated coverage on Pardes Biosciences Inc PRDS. The price target seems to have been set at $18.00 for Pardes Biosciences. The stock has a 52-week-high of $17.76 and a 52-week-low of $5.54. At the end of the last trading period, Pardes Biosciences closed at $5.64.

Berenberg initiated coverage on BigCommerce Holdings Inc BIGC with a Hold rating. The price target for BigCommerce Holdings is set to $21.00. BigCommerce Holdings earned $0.17 in the fourth quarter, compared to $0.12 in the year-ago quarter. The current stock performance of BigCommerce Holdings shows a 52-week-high of $72.20 and a 52-week-low of $17.90. Moreover, at the end of the last trading period, the closing price was at $18.21.

With a Equal-Weight rating, Barclays initiated coverage on Tyler Technologies Inc TYL. The price target seems to have been set at $445.00 for Tyler Technologies. For the fourth quarter, Tyler Technologies had an EPS of $1.75, compared to year-ago quarter EPS of $1.39. At the moment, the stock has a 52-week-high of $557.55 and a 52-week-low of $384.38. Tyler Technologies closed at $391.52 at the end of the last trading period.

With a Buy rating, HSBC initiated coverage on Air Lease Corp AL. The price target seems to have been set at $50.00 for Air Lease. In the fourth quarter, Air Lease showed an EPS of $1.75, compared to $1.30 from the year-ago quarter. The stock has a 52-week-high of $52.96 and a 52-week-low of $33.41. At the end of the last trading period, Air Lease closed at $38.42.

Baird initiated coverage on Toast Inc TOST with an Outperform rating. The price target for Toast is set to $25.00. At the moment, the stock has a 52-week-high of $69.93 and a 52-week-low of $15.82. Toast closed at $16.26 at the end of the last trading period.

With an Outperform rating, Bernstein initiated coverage on Peloton Interactive Inc PTON. The price target seems to have been set at $40.00 for Peloton Interactive. For the second quarter, Peloton Interactive had an EPS of $1.39, compared to year-ago quarter EPS of $0.18. At the moment, the stock has a 52-week-high of $129.70 and a 52-week-low of $20.11. Peloton Interactive closed at $20.20 at the end of the last trading period.

With an Underperform rating, Bernstein initiated coverage on Lululemon Athletica Inc LULU. The price target seems to have been set at $260.00 for Lululemon Athletica. Lululemon Athletica earned $1.62 in the third quarter, compared to $1.16 in the year-ago quarter. The current stock performance of Lululemon Athletica shows a 52-week-high of $485.82 and a 52-week-low of $283.00. Moreover, at the end of the last trading period, the closing price was at $289.24.

Bernstein initiated coverage on Burlington Stores Inc BURL with an Outperform rating. The price target for Burlington Stores is set to $230.00. Burlington Stores earned $2.53 in the fourth quarter, compared to $2.44 in the year-ago quarter. At the moment, the stock has a 52-week-high of $357.34 and a 52-week-low of $171.15. Burlington Stores closed at $194.97 at the end of the last trading period.

With a Market Perform rating, Bernstein initiated coverage on Stitch Fix Inc SFIX. The price target seems to have been set at $11.00 for Stitch Fix. For the second quarter, Stitch Fix had an EPS of $0.28, compared to year-ago quarter EPS of $0.20. The stock has a 52-week-high of $69.20 and a 52-week-low of $8.75. At the end of the last trading period, Stitch Fix closed at $9.18.

Evercore ISI Group initiated coverage on Planet Fitness Inc PLNT with an Outperform rating. The price target for Planet Fitness is set to $130.00. Planet Fitness earned $0.26 in the fourth quarter, compared to $0.17 in the year-ago quarter. The current stock performance of Planet Fitness shows a 52-week-high of $99.60 and a 52-week-low of $67.89. Moreover, at the end of the last trading period, the closing price was at $81.03.

With an Outperform rating, Evercore ISI Group initiated coverage on Xponential Fitness Inc XPOF. The price target seems to have been set at $34.00 for Xponential Fitness. The stock has a 52-week-high of $24.73 and a 52-week-low of $9.87. At the end of the last trading period, Xponential Fitness closed at $20.02.

Oppenheimer initiated coverage on BioVie Inc BIVI with an Outperform rating. The price target for BioVie is set to $9.00. In the second quarter, BioVie showed an EPS of $0.22, compared to $0.22 from the year-ago quarter. The stock has a 52-week-high of $23.86 and a 52-week-low of $2.52. At the end of the last trading period, BioVie closed at $2.77.

Oppenheimer initiated coverage on Horizon Therapeutics PLC HZNP with an Outperform rating. The price target for Horizon Therapeutics is set to $140.00. For the fourth quarter, Horizon Therapeutics had an EPS of $1.41, compared to year-ago quarter EPS of $1.28. The current stock performance of Horizon Therapeutics shows a 52-week-high of $120.53 and a 52-week-low of $79.81. Moreover, at the end of the last trading period, the closing price was at $101.36.

See all analyst ratings initiations.